Magnetic Focus Lateral Flow Assay for Cervical Cancer Biomarker Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cervical cancer screening methods in low- and middle-income countries (LMICs) are hindered by the lack of effective, affordable, and accessible technologies for early detection and diagnosis, often resulting in late diagnosis and high mortality rates due to limited resources and infrastructure.
Innovation Solution
The development of magnetic focus enhanced lateral flow assays (mLFIA) that utilize gold-based magnetic nanoparticles and horseradish peroxidase (HRP) enzyme labels to create an ultrasensitive, point-of-care diagnostic tool capable of detecting cervical cancer biomarkers at very low concentrations without the need for specialized equipment or trained professionals.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional cytology-based screening tests (Pap smear) are used, then cervical cancer can be detected with reasonable accuracy, but the requirement for trained personnel and extensive clinical infrastructure makes it impossible to implement in low-resource settings
Solution Approach 1:
The invention extracts the essential detection function from the complex Pap smear system by using magnetic beads conjugated with antibodies to specifically capture target proteins (p16 and Ki-67) directly from cervical samples. This eliminates the need for trained cytologists and extensive laboratory infrastructure while maintaining detection accuracy through magnetic separation and colorimetric readout.
Solution Approach 2:
The invention introduces magnetic beads as an intermediary carrier that conjugates with antibodies specific to cervical cancer markers. These magnetic bead-antibody complexes serve as mediators to capture target proteins from samples, enabling specific detection without requiring complex equipment or expert interpretation, thus bridging the gap between accuracy and simplicity.
2Ease of operation
If visual inspection with acetic acid (VIA) is used, then the test is simple and inexpensive, but the lack of sensitivity and specificity leads to high false positive rates and over-referral
Solution Approach 1:
The invention uses colorimetric detection where magnetic bead-antibody complexes bound to target proteins produce visible color changes upon addition of substrate. This provides objective, quantifiable results with clear positive/negative indicators, eliminating the subjective interpretation problems of VIA while maintaining visual simplicity suitable for point-of-care use in resource-limited settings.
3Measurement precision
If high sensitivity detection methods are used to detect cervical cancer biomarkers, then early diagnosis is improved, but the requirement for specialized equipment and laboratories reduces accessibility in low-resource countries
Solution Approach 1:
The invention replaces complex mechanical and electronic detection systems with a simple magnetic separation and colorimetric readout system. Magnetic beads provide sensitive capture of target proteins through magnetic field application, and color development provides visual detection without requiring sophisticated equipment. This substitution enables high sensitivity detection to be performed with minimal infrastructure, dramatically improving accessibility in low-resource settings.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The mLFIA devices provide unprecedented sensitivity and specificity, enabling the detection of cervical cancer biomarkers at the femtogram level, facilitating early diagnosis and treatment, and can be used in resource-limited settings without requiring extensive clinical infrastructure.
Implementation Method 1
at least one magnet positioned at or near the capture area of the one or more strips, wherein the at least one magnet is configured to magnetically interact with the target analyte complex
Implementation Method 2
utilize gold-based magnetic nanoparticles and horseradish peroxidase (HRP) enzyme labels to create an ultrasensitive, point-of-care diagnostic tool capable of detecting cervical cancer biomarkers at very low concentrations
Data Source
AI summary
Devices, systems, and methods are provided for magnetic focus enhanced lateral flow assays. The devices and systems are ultrasensitive and provide for the visual detection of the presence or absence of one or more target analytes—which may include pathogens, proteins, or even molecules smaller than the foregoing—even when such analytes are only present in very limited amounts. The devices and systems include an immunostrip with a magnet positioned adjacent thereto, and magnetic probes specific to a target analyte that bind to the target analyte with specificity if present within a fluid sample to be tested. Methods are also provided for detecting one or more target analytes using magnetic focus, such methods including a step of controlling movement of a target analyte complex on an immunostrip incorporating a magnetic field, where such control slows a flow of the target analyte complex through a capture area on the immunostrip.